A Clinical study to evaluate the effect of Tilwaka Kshara as topical application in 30 participants for removing Warts and Skin Tags

A single-arm, open-labelled clinical study to evaluate the effect of Tilwaka teekshna pratisaraneeya kshara in the management of Charmakeela - nil

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/06/088256

Enrollment

Registered

2025-06-04

Start date

Unknown

Completion date

Unknown

Last updated

2025-09-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L089- Local infection of the skin and subcutaneous tissue, unspecified

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1.Subjects with warts or skin tags on neck, upper limbs or lower limbs. 2.Subjects of age group 18 -60 years irrespective of gender, religion, occupation and socio- economic status. 3.Subjects who are willing to provide informed consent.

Exclusion criteria

Exclusion criteria: 1.Skin lesions more than 5mm size. 2.Pigmented lesions, Neurofibroma, Genital warts and Plantar warts. 3.Subjects contraindicated for Pratisaraneeya ksharakarma. 4.Diagnosed with systemic conditions such as Tuberculosis, HIV, Diabetes mellitus, Hypertension, Bleeding Disorders and Carcinoma. 5.Warts displaying features suggestive of a carcinomatous appearance. 6.Subjects taking anti-coagulants. 7.Subjects with a history of allergy.

Design outcomes

Primary

Measure	Time frame
To evaluate the effectiveness, safety, and clinical applicability of Tilwaka Teekshna Pratisaraneeya Kshara as a topical application in the management of Charmakeela. 1.Number of days taken for complete shedding of the lesion 2.Reduction in size of the lesion (in mm) 3.Scar assessment after healingTimepoint: Assessment of size of lesion will be done before treatment (0th day), 7th day and 14th day after treatment. Scar assessment will be on 14th day and 21st day. Follow up assessment will be done on 21st day after treatment.	—

Measure

Time frame

To evaluate the effectiveness, safety, and clinical applicability of Tilwaka Teekshna Pratisaraneeya Kshara as a topical application in the management of Charmakeela. 1.Number of days taken for complete shedding of the lesion 2.Reduction in size of the lesion (in mm) 3.Scar assessment after healingTimepoint: Assessment of size of lesion will be done before treatment (0th day), 7th day and 14th day after treatment. Scar assessment will be on 14th day and 21st day. Follow up assessment will be done on 21st day after treatment.

—

Secondary

Measure	Time frame
NILTimepoint: NIL	—

Countries

India

Contacts

Public ContactPriya K Yesudas

Pankajakasthuri Ayurveda Medical College and PG Centre Kattakada Thiruvananthapuram

priyayesudas94@gmail.com8075262851

Outcome results